FLT3 and acute myeloid leukemia: AML with FLT3-ITD mutation had higher GNA15 transcript levels than those without FLT3-ITD mutation (889.85% [171.59%-3351.42%] vs 625.16% [67.87%-1656.21%], P=0.0002, Figure 1E).